IL-23 shares a common p40 subunit with IL-12 that, in many ways, antagonizes IL-23 in cancers by boosting anti-tumor immunity (Ngiow et al., 2013, Teng et al., 2012) and promoting injury resolution and subsequent tissue re-normalization (Ngiow et al., 2013). Here, IL23A is linked to neoplasm.